DegQ is a serine protease that is highly homologous to HtrA, an important virulence determinant of Salmonella enterica serovar Typhimurium. We examined if DegQ is involved in serovar Typhimurium pathogenesis. A serovar Typhimurium degQ mutant was as virulent as the wild-type strain in mice. However, a serovar Typhimurium htrA degQ mutant survived less well in murine organs, particularly in the liver, than a serovar Typhimurium htrA mutant. DegQ is not essential for serovar Typhimurium pathogenesis but may play a small role during salmonella growth at systemic sites.
The serine protease HtrA is involved in the survival of Salmonella enterica serovar Typhimurium within macrophages in vitro and host tissues in vivo (6, 7, 9) . HtrA seems to be particularly important for survival of serovar Typhimurium at systemic sites in organs, such as the liver and spleen (4, 6) . HtrA is a peripheral membrane protein that is active in the periplasm, and it possesses both protease and chaperone activities (9, 11) . The main function of HtrA is believed to be degradation or refolding of damaged proteins that accumulate in the periplasm due to various insults (extracytoplasmic or envelope stress) (9) . Expression of the htrA gene is positively controlled by two regulators of the extracytoplasmic stress response, the alternative sigma factor E and the two-component regulator CpxAR (2, 3, and unpublished data). The importance of HtrA to serovar Typhimurium in vivo is somewhat surprising, because Salmonella spp. (and many other gramnegative bacteria) possess a second highly homologous protease, DegQ (HhoA), that is also active in the periplasm (9) . The main domains of HtrA, the serine protease domain and the two PDZ domains, are highly conserved between HtrA and DegQ (9). Where they has been compared, the substrate specificities of HtrA and DegQ were identical (8) .
We wished to see if DegQ plays a role in S. enterica serovar Typhimurium pathogenesis and also if DegQ was important in the absence of HtrA. To this end we inactivated the degQ gene of the wild-type (WT) mouse virulent strain S. enterica serovar Typhimurium SL1344 and an isogenic htrA mutant, BRD915 (1). The complete degQ open reading frame was amplified by PCR. The cloned gene was inactivated by digestion with EcoRV, which removed an internal 420-bp fragment from the center of the gene. A 1,252-bp HincII fragment from pUC4K containing the kanamycin resistance gene (aphI) was blunt-end ligated with EcoRV-digested degQ. The degQ::Km r construct was cloned into the suicide plasmid pRDH10 and was used to inactivate the gene of strains SL1344 and BRD915 as previously described (6) . The genotype of the resulting degQ and htrA degQ strains was confirmed by PCR and Southern blotting, and the phenotype was confirmed by Western blotting with anti-HtrA and anti-DegQ antisera (data not shown).
The colony morphology of both the degQ and htrA degQ mutants appeared normal on solid media, and both mutants grew normally at 37 and 42°C in Luria-Bertani broth (data not shown).
The virulence of the serovar Typhimurium degQ mutant was compared to that of its WT parent. Initially the strains were compared by competition assay. An inoculum containing ϳ10 3 CFU of each strain was inoculated intraperitoneally into groups of mice, and 3 days later animals were euthanized. Liver and spleens were removed and homogenized, and the number of CFU of each strain present determined. The competitive index for degQ versus that of WT was ϳ1.0, indicating that there was no difference in the ability of the two strains to compete in vivo following parenteral challenge. To examine if the degQ mutation impaired the ability of serovar Typhimurium to infect mice via the natural route of infection, groups of mice were inoculated orally with either the WT or degQ strain. There was no difference in the growth kinetics of the two strains in the Peyer's patches (PPs), mesenteric lymph nodes (MLN), liver, and spleen (Fig. 1) .
To determine if the absence of degQ further attenuated an S. enterica serovar Typhimurium htrA mutant, we inoculated the htrA and htrA degQ mutants individually into mice intravenously and monitored their persistence in the liver and spleen (Fig. 2) . The htrA degQ double mutant survived less well in both the liver and spleen than the htrA mutant, but the difference in the numbers of the two strains was only statistically different (P Ͻ 0.05) in the liver at days 3 and 4. We examined if the addition of the degQ mutation affected the ability of a serovar Typhimurium htrA mutant to colonize murine tissues when administered orally to mice. There was no difference in the persistence of the two mutants in the PPs and MLN (data not shown), but it was not possible to discern any difference in the ability of the mutants to persist in the liver and spleen because there were very few, if any, organisms isolated from these sites at any time point (data not shown). We also found that the degQ mutation did not diminish the ability of a serovar Typhimurium htrA mutant to act as a single-dose live oral vaccine against serovar Typhimurium (data not shown)
The DegQ protein is not essential for S. enterica serovar Typhimurium to cause infection, at least in mice. HtrA appears to be more important for serovar Typhimurium to cause systemic infection than to grow in tissues associated with the gut (4, 6, and this study). At systemic sites, the spleen and specifically the liver, it would seem that DegQ can partially compensate for the absence of HtrA. As mentioned, it is not readily apparent why DegQ cannot more efficiently substitute for HtrA in vivo. It may be due to differences in the regulation of degQ and htrA; degQ is constitutively expressed, whereas htrA is positively controlled by regulators that respond to envelope stress and is upregulated within macrophages in vitro and in murine tissues in vivo (5, 9, 10). Alternatively, sequence or structural variation between HtrA and DegQ may determine differences in the function of HtrA and DegQ in vivo. We are presently investigating these different possibilities. 
